Cardiol Therapeutics (CRDL) Cash from Operations (2020 - 2026)
Cardiol Therapeutics' (CRDL) quarterly Cash from Operations came in at 5481899.32 in Q1 2026, down 9.96% YoY from 6087964.66 in Q1 2025, and down 46.3% on a QoQ basis from 3746989.52 in Q4 2025.
Cardiol Therapeutics (CRDL) Cash from Operations (2020 - 2026) Analysis & Trends
Cardiol Therapeutics (CRDL) has 7 years of Cash from Operations data on file, last reported at 5481899.32 in Q1 2026.
- Quarterly Cash from Operations fell 9.96% year-over-year to 5481899.32 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 17545050.36 (up 3.47% YoY) and the FY2025 annual result came in at 17105842.3, up 4.65% from the prior year.
- Cash from Operations declined to 5481899.32 in Q1 2026, from 3746989.52 in the prior quarter.
- In the past five years, Cash from Operations ranged from a high of 1298440.3 in Q3 2022 to a low of 9242330.31 in Q4 2022.
- A 5-year average of 4722016.0 and a median of 4748595.89 in 2023 frame the typical range for Cash from Operations.
- The widest YoY moves for Cash from Operations: up 74.4% in 2022, down 191.52% in 2022.
- Tracing CRDL's Cash from Operations over 5 years: stood at 9242330.31 in 2022, then soared by 48.62% to 4748595.89 in 2023, then grew by 15.68% to 4003953.99 in 2024, then grew by 6.42% to 3746989.52 in 2025, then slumped by 46.3% to 5481899.32 in 2026.
- The last three Cash from Operations figures came in at 5481899.32 (Q1 2026), 3746989.52 (Q4 2025), and 5031955.39 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 411.00 Mn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 655.00 Mn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 800.69 Mn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 313.60 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 381.80 Mn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 136.40 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 277.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Cardiol Therapeutics | 215.50 Mn | 196.65 Mn | - | -3.17 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -5.48 Mn |
| Mar 31, 2026 | -5.48 Mn |
| Dec 31, 2025 | -3.75 Mn |
| Dec 31, 2025 | -3.75 Mn |
| Sep 30, 2025 | -5.03 Mn |
| Sep 30, 2025 | -5.03 Mn |
| Jun 30, 2025 | -3.28 Mn |
| Jun 30, 2025 | -3.28 Mn |
| Mar 31, 2025 | -4.99 Mn |
| Mar 31, 2025 | -4.99 Mn |
| Dec 31, 2024 | -4.00 Mn |
| Dec 31, 2024 | -4.00 Mn |
| Sep 30, 2024 | -5.70 Mn |
| Sep 30, 2024 | -5.70 Mn |
| Jun 30, 2024 | -3.49 Mn |
| Jun 30, 2024 | -3.49 Mn |
| Mar 31, 2024 | -5.14 Mn |
| Mar 31, 2024 | -5.14 Mn |
| Dec 31, 2023 | -4.75 Mn |
| Dec 31, 2023 | -4.75 Mn |